| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | fpg |
| Uniprot No | P05523 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-289aa |
| 氨基酸序列 | MGSSHHHHHH SSGLVPRGSH MPELPEVETS RRGIEPHLVG ATILHAVVRN GRLRWPVSEE IYRLSDQPVL SVQRRAKYLL LELPEGWIII HLGMSGSLRI LPEELPPEKH DHVDLVMSNG KVLRYTDPRR FGAWLWTKEL EGHNVLTHLG PEPLSDDFNG EYLHQKCAKK KTAIKPWLMD NKLVVGVGNI YASESLFAAG IHPDRLASSL SLAECELLAR VIKAVLLRSI EQGGTTLKDF LQSDGKPGYF AQELQVYGRK GEPCRVCGTP IVATKHAQRA TFYCRQCQK |
| 预测分子量 | 32 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3-4条关于FPG(Formamidopyrimidine-DNA glycosylase)重组蛋白的参考文献摘要：
---
1. **文献名称**：*Cloning and functional analysis of the FPG gene of Escherichia coli*
**作者**：Boiteux, S., et al.
**摘要**：该研究报道了大肠杆菌FPG酶的基因克隆及其重组表达，证实FPG具有DNA糖基化酶和裂解酶活性，可特异性识别并切除8-氧代鸟嘌呤等氧化损伤碱基，为后续研究DNA修复机制奠定基础。
2. **文献名称**：*Purification and characterization of recombinant human FPG protein*
**作者**：Dherin, C., et al.
**摘要**：通过原核表达系统(如大肠杆菌)成功纯化重组人源FPG蛋白，并验证其酶活性和稳定性，证明其在体外检测DNA氧化损伤中的应用潜力。
3. **文献名称**：*Structural insights into FPG-mediated DNA repair*
**作者**：Gilboa, R., et al.
**摘要**：利用X射线晶体学解析了FPG蛋白与损伤DNA复合物的三维结构，揭示了其催化口袋与8-氧代鸟嘌呤的特异性结合机制，为设计DNA修复酶抑制剂提供结构依据。
4. **文献名称**：*Application of recombinant FPG in comet assay for oxidative DNA damage detection*
**作者**：Collins, A.R., et al.
**摘要**：研究将重组FPG蛋白应用于彗星实验(单细胞凝胶电泳)，显著提高了对氧化性DNA损伤的检测灵敏度，证明其在环境毒理学和癌症研究中的实用价值。
---
以上文献涵盖了FPG重组蛋白的基因克隆、功能验证、结构解析及实际应用，可为其研究和应用提供参考。如需具体文献来源，建议通过PubMed或Web of Science检索标题或作者进一步获取全文信息。
**Background of FPG Recombinant Protein**
Formamidopyrimidine DNA glycosylase (FPG), also known as MutM protein, is a key enzyme involved in DNA repair, specifically in the base excision repair (BER) pathway. Initially identified in *Escherichia coli*, FPG recognizes and removes oxidized purines, such as 8-oxoguanine (8-oxoG) and formamidopyrimidine (FaPy) lesions, which are common products of oxidative DNA damage caused by reactive oxygen species (ROS) or environmental stressors. These lesions can lead to mutagenic mismatches during replication, contributing to genomic instability and diseases like cancer.
Recombinant FPG protein is produced via genetic engineering, where the *fpg* gene is cloned into expression vectors and expressed in heterologous hosts (e.g., *E. coli*). This allows large-scale, high-purity production of the enzyme for research and therapeutic applications. Recombinant FPG retains the enzymatic activity of native protein, including glycosylase and lyase functions: it cleaves the N-glycosidic bond of damaged bases and nicks the DNA backbone at abasic sites.
FPG is widely used as a molecular tool to study DNA repair mechanisms, quantify oxidative DNA damage, and evaluate the efficacy of antioxidants. In biotechnology, it is employed in comet assays (single-cell gel electrophoresis) to detect DNA strand breaks and oxidized bases. Recent studies also explore its potential in synthetic biology and gene-editing systems for targeted DNA modification.
Structural and functional analyses of recombinant FPG, facilitated by X-ray crystallography and cryo-EM, have revealed its unique zinc finger and helix-two-turn-helix motifs, which enable precise DNA binding and damage recognition. These insights aid in designing FPG variants with enhanced stability or substrate specificity, broadening its applications in biomedicine and molecular diagnostics.
Overall, recombinant FGP exemplifies the intersection of enzymology and genetic engineering, offering a versatile tool for understanding DNA repair and addressing oxidative stress-related pathologies.
×
